HIA and RE Botanicals filed a legal action against the DEA on Friday regarding the Interim Final Rule it issued on August 21, 2020. We are proud to be part of the legal team.
Category: Legal Advocacy
I recently had a wide-ranging discussion about cannabinoids, hemp, and marijuana with Kevin Carrillo of the Cannabinoid Connect podcast. Watch it here.
Do we really want to deny our military Service Members access to otherwise lawful products that could provide significant relief just to preserve the integrity of an outmoded drug testing program?
A physician’s education about cannabis medicine, and her patient’s treatment options, should not depend on their state of residence. Patient access should be based on sound science and physicians should receive comprehensive and uniform education regardless of the state in which they practice.
April 20 has rapidly evolved into a multifaceted, global celebration of cannabis that emphasizes unity, the power of grass-roots advocacy, and a world in which social justice and a sustainable future can be achieved.
The notion that impairment can be assumed or not based solely on specific concentrations of THC or its metabolites in a driver’s blood or urine is plainly wrong.
The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data.
As a service to our current clients and readers during these difficult times, we are offering a free 20-minute phone call to address your pressing issues – no strings attached.
In this article, I will provide a summary of THCA, delta-9 THC, delta-8 THC, THCP, THCV and then conclude with a discussion of the various laws that impact them.